Program News
News and stories about the UNC Lineberger Urologic Oncology Program
-
Treatment advances, predictive biomarkers stand to improve bladder cancer care
In an editorial, Matthew Milowsky, MD, FASCO, wrote that the promise of incorporating new treatments and predictive biomarkers to select the right patient for the right treatment every time offers a bright future for bladder cancer patients.
-
Prostate cancer treatment: managing side effects
Urologic oncologist Ray Tan, MD, provides an overview of prostate cancer treatments and their side effects, and encourages talking through different options to make a shared decision.
-
Kim, Rose highlight advances in kidney cancer research and care in JAMA
William Kim, MD, and Tracy Rose, MD, MPH, published a review highlighting new scientific insights that have led to advances in kidney cancer treatment and increased survival rates.
-
New program cuts wait times in half for patients with suspected prostate cancer
A new program being used in the UNC Department of Urology is helping to expand access to rapid, high quality urologic care.
-
Nielsen selected for NAM Scholars in Diagnostic Excellence program
Matthew Nielsen, MD, MS, was selected by the National Academy of Medicine to participate in the 2024 class of the NAM Scholars in Diagnostic Excellence program.
-
Three things to know about prostate cancer
Prostate cancer is the most common cancer in men, with an even higher incidence in Black men. Urologic oncologist Matt Nielsen, MD, MS, FACS, shares three things to know about prostate cancer.
-
Supporting men after testicular cancer
Testicular cancer is the most common cancer among young adult males. While testicular cancer is very treatable, “there are a lot of survivorship implications,” says Hung-Jui “Ray” Tan, MD.
-
Opening up about prostate cancer
Albert Brunson didn’t tell anyone but his wife when he was diagnosed with prostate cancer. But a neighbor’s death from metastatic prostate cancer changed his mind about sharing his story.